Early intensive therapy for multiple sclerosis leads to better long-term outcomes, despite being perceived as high risk  New findings by researchers at Cardiff Uni...

First commercial program under Bavarian Nordic and Janssen Vaccines & Prevention B.V. collaboration advancing into clinical trialsA therapeutic vaccine may repre...

Clinerion will offer its services to hospitals in Georgia, bringing them access to international clinical studies and the use of Patient Network Explorer for academi...

FRAMES trial expected to initiate patient recruitment in upcoming weeks in Spain, Belgium and other European countriesProfessor Alexandra Durr, principal investigato...

In a crowded field of nonalcoholic steatohepatitis (NASH) hopefuls, Intercept Pharmaceuticals looks to be pulling ahead. In a pivotal phase 3 study, the biotech’s ob...